Refine by
Drug Designation Equipment & Supplies
85 equipment items found
by:Vybion based inMonterey, CALIFORNIA (USA)
INT41 has received Orphan Drug Designation from the FDA for Huntington’s disease. IND enabling studies for INT41 Gene Therapy for Huntington’s disease are in place following a preIND meeting with the FDA in in February 2022 in response to the briefing book prepared by our consultants at Latham BioPharm, a world class consulting group based in ...
Manufactured by:Confo Therapeutics based inGhent/Zwijnaarde, BELGIUM
With its unique antibody-based technology, Confo Therapeutics aims to overcome the current limitations of GPCR drug discovery in order to fully realize the potential of GPCRs as drug ...
by:Sibylla Biotech S.p.A. based inVerona, ITALY
The PPI-FIT (Pharmacological Protein Inactivation by Folding Intermediate Targeting) technology, of which Sibylla is the exclusive licensee, is a paradigm shift in rational drug design. The basic task of drug design is to find a small molecule able to bind a biological target -such as a protein- so to modulate or block its ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-2900, Tonix’s proprietary potentiated intranasal oxytocin is in the pre-Investigational New Drug (IND) stage as a candidate for the treatment of Prader-Willi syndrome (PWS) and non-organic failure to thrive disease. TNX-2900 has been granted Orphan Drug Designation (ODD) in the US by the FDA for the treatment of ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
By encapsulating molecules with poor solubility in polymeric micelle nanoparticles, TLC’s technology can increase the solubility of a drug. This allows a larger quantity to be delivered in a single dose, which can enable new forms of administration. For molecules that are too insoluble to be practical as stand-alone therapies, lipid encapsulation may be the key to ...
Manufactured by:Vivesto AB based inSolna, SWEDEN
Apealea is approved by the European regulatory authority EMA for use in combination with carboplatin for the treatment of adult patients with first relapse of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer. Apealea has also received orphan drug designation from the US regulatory authority FDA for the treatment of ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Introducing fluorine atom(s) into bioactive organic compounds has become a leading strategy for drug design and lead optimization. In drug synthesis strategy, fluorine is frequently employed to modify biologically relevant properties such as metabolic stability, basicity, lipophilicity and bioavailability. Additionally, the binding affinity of ...
Manufactured by:Cellphire Therapeutics, Inc. based inRockville, MARYLAND (USA)
The product is currently in a Phase 2 clinical trial in bleeding thrombocytopenic patients. Thrombosomes has also been given orphan drug designation for the treatment of Acute Radiation Sickness by the U.S. Food and Drug ...
Manufactured by:Seres Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
SER-287 is a consortium of multiple bacterial spores manufactured by fractionating and purifying targeted bacteria from stool of healthy human donors. SER-287 has been granted Fast Track designation and Orphan Drug designation by the FDA. A completed SER-287 Phase 1b clinical study demonstrated a statistically significant difference in the ...
Manufactured by:Protara Therapeutics, Inc. based inNew York, NEW YORK (USA)
Because PN patients cannot sufficiently absorb adequate levels of choline and no available PN formulations contain sufficient amounts of choline to correct this deficiency, PN patients often experience a prolonged progression to hepatic failure and death, with the only known intervention being a dual small bowel / liver transplant. If approved, IV choline chloride would be the first approved ...
Manufactured by:Cabaletta Bio, Inc. based inPhiladelphia, PENNSYLVANIA (USA)
Our lead product candidate, DSG3-CAART, is being developed to treat mucosal pemphigus vulgaris (mPV), a blistering skin disease that affects mucous membranes. mPV is caused by autoantibodies that attack the cell adhesion protein desmoglein 3, or DSG3. DSG3-CAART is designed to selectively target and kill the B cells that produce DSG3 antibodies while preserving the healthy B ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
Dipraglurant is a novel orally available highly selective metabotropic glutamate receptor subtype 5 negative allosteric modulator (mGlu5 NAM) which has completed Phase 1 and demonstrated efficacy in a Phase 2a proof of concept study for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease (PD-LID). This is a disease with significant commercial opportunity as ...
Manufactured by:Notitia Biotechnologies based inMonmouth Junction, NEW JERSEY (USA)
NM108 is an investigational botanical drug that is designed to treat diseases by promoting the growth of either the existing or replenished Foundation Guild™ bacteria in a patient's gut microbiome. NM108 is currently in phase 2 trial as well as available for Expanded Access (compassionate ...
Manufactured by:Nemera based inLa Verpillière, FRANCE
Our portfolio of disposable pens includes variable and fixed dose devices for automatic and manual drug administration, combining modern design with high intuitiveness of use for multidose therapies. Nemera offers three disposable pen injector development platforms with wide customization and drug capability options, to serve fulfilling of ...
Manufactured by:Daiichi Sankyo Company Limited based inTokyo, JAPAN
TURALIO (pexidartinib) is an oral small molecule that targets colony stimulating factor 1 receptor (CSF1R), KIT proto-oncogene receptor tyrosine kinase (KIT), and FMS-like tyrosine kinase 3 (FLT3) harboring an internal tandem duplication (ITD) ...
Manufactured by:Rea Tape based in, SOUTH KOREA
THIN GENTLE SILKY FABRICs: REA Tape Premium is made from 100% rayon. LATEX FREE: Is 100% latex free. DRUG FREE: Is 100% free from any medical substances or pharmaceutical drugs. HYPOALLERGENIC: Is designed to minimize the possibility of an allergic response. BREATHABLE: Allows freely for the passage of air and moisture. JAPANESE MEDICAL GLUE: ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
MolEQ designs novel compounds by optimizing multiple properties such as efficacy and toxicity of a lead ...
by:Palvella Therapeutics. based inWayne, PENNSYLVANIA (USA)
QTORINTM rapamycin 3.9% is a novel topical therapy being studied for Pachyonychia Congenita (PC). We are currently enrolling our phase 3 study in ...
Manufactured by:Rea Tape based in, SOUTH KOREA
100% PURE COTTON: Is made from 100% pure natural cotton fibers. LATEX FREE: Is 100% latex free. DRUG FREE: Is 100% free from any medical substances or pharmaceutical drugs. HYPOALLERGENIC: Is designed to minimize the possibility of an allergic response. BREATHABLE: Allows freely for the passage of air and moisture. JAPANESE MEDICAL GLUE: Uses ...
Manufactured by:Rea Tape based in, SOUTH KOREA
100% PURE COTTON: Is made from 100% pure natural cotton fibers. LATEX FREE: Is 100% latex free. DRUG FREE: Is 100% free from any medical substances or pharmaceutical drugs. HYPOALLERGENIC: Is designed to minimize the possibility of an allergic response. BREATHABLE: Allows freely for the passage of air and moisture. JAPANESE MEDICAL GLUE: Uses ...